Redness at injection site that looked like a pimple or cyst might form (approx. 3/16ths of an inch), which receded with larger area of redness and swelling (about the size of my hand) went down; Redness at injection site that looked like a pimple or cyst might form (approx. 3/16ths of an inch), which receded with larger area of redness and swelling (about the size of my hand) went down; Redness at injection site that looked like a pimple or cyst might form (approx. 3/16ths of an inch), which receded with larger area of redness and swelling (about the size of my hand) went down; Hard lump about the size of a half dollar coin which also receded (3.5 days) slightly below injection site; Emotional dysregulation (mainlysudden bouts of crying) which lasted 3days.; Period-like cramping stillpersisting on 5th day (today,4/7/2021).; Have had 4 bouts ofdizziness that passed quickly; Persistent fatigue and thirst.; Thirst; Other symptoms indicated as common(sore throat, mild fever) were over byday 3.; Other symptoms indicated as common(sore throat, mild fever) were over byday 3.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunization. Medical history included fibromyalgia, endometriosis, polycystic ovarian syndrome (PCOS), cystitis interstitial, hypothyroidism and hypertension. The patient had fruit allergy to raw pineapple. The patient previously received pneumococcal vaccine (pneumonia vaccine), INTUNIV, EFFEXOR on an unknown date and experienced allergy. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration in the left arm on 09Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced redness at injection site that looked like a pimple or cyst might form approximately 3/16ths of an inch, which receded with larger area of redness and swelling (about the size of her hand) went down after about 3 days. Hard lump about the size of a half dollar coin which also receded (3.5 days) slightly below injection site. Emotional dysregulation (mainly sudden bouts of crying) which lasted 3 days. Period-like cramping still persisting on 5th day (07Apr2021). Have had 4 bouts of dizziness that passed quickly, but no difficulty breathing or irregular heartbeat. Persistent fatigue and thirst. Other symptoms indicated as common (sore throat, mild fever) were over by day 3. The events did not result in a visit to doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injection site redness, injection site cyst, vaccination site swelling, vaccination site lump, crying abnormal, sore throat and the fever were all recovered with sequelae on 06Apr2021 however the dizziness, fatigue and thirst were also recovered with sequalae while the period like cramp was not recovered at the time of this report.    No follow-up attempts are possible. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Cc reporter's suffix added. Past Drug coded via who drug. Narrative "Period-like cramping still persisting on 5th day (04Apr2021)." updated to "Period-like cramping still persisting on 5th day (07Apr2021)." Description as Reported of event "Vaccination site lump" updated.